An observational study in Lung Cancer, sponsored by Memorial Sloan Kettering Cancer Center. Active, not recruiting at 7 sites in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-02-05.
Sponsored by Memorial Sloan Kettering Cancer Center · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 108 studies in Lung Neoplasms by Memorial Sloan Kettering Cancer Center — 9 open to participants now, 20 under way, none of them phase 3. Lung Neoplasms · Memorial Sloan Kettering Cancer Center.
Among the 108 studies in Lung Neoplasms by Memorial Sloan Kettering Cancer Center, this one is the 4th largest by enrollment of the 30 observational ones that give a count, is one of 3 that started in 2016, is one of 30 observational ones, reaches primary completion later than 1 of the 19 other live ones, and was the 85th registered.
5,436 studies on the registry are indexed under Lung Neoplasms; 1,350 are open to participants now.
Browse Lung Neoplasms studies →9 of the 108 studies in Lung Neoplasms by Memorial Sloan Kettering Cancer Center are open now, in 2 countries. Recruiting first, the newest first:
Memorial Sloan Kettering Cancer Center · Sites in United States
Ages 40–74 · Healthy volunteers
Memorial Sloan Kettering Cancer Center · Sites in United States
Ages 18+
Memorial Sloan Kettering Cancer Center · Sites in United States
Ages 50–80 · Healthy volunteers
Memorial Sloan Kettering Cancer Center · Sites in United States
Ages 18+
Memorial Sloan Kettering Cancer Center · Sites in United States, Canada
Ages 18+
By country, each count listing its studies:
Of the 997 Lung Neoplasms studies recruiting now, 686 (69%) set no upper age limit and 143 (14%) stop at 75 or younger; 45 take children under 18; 143 take healthy volunteers.
This study: 18 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
108 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 29 · Phase 2 41 · Phase 3 2
First in 1991; this study’s year is marked. 3 started in 2016.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 294 is above the median of 200 across 1,436 observational studies indexed under Lung Neoplasms.
Median enrollment 48 across the 62 interventional studies, 78 across the 30 observational. Of the 87 that completed or were terminated, 20 (23%) have results posted.
This tab as a report to print or save as PDF → With an account.
Memorial Sloan Kettering Cancer Center is the lead sponsor of 1,964 studies on the registry; 325 are open to participants now.
Of its 135 completed or terminated interventional studies of FDA-regulated products, 71 (53%) have results posted.
15 of the studies in Lung Neoplasms by Memorial Sloan Kettering Cancer Center that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT02732834Memorial Sloan Kettering Cancer CenterClinician-Patient Communication in Lung Cancer Care | 2027-01 |
| NCT04734145Memorial Sloan Kettering Cancer CenterUsing e-Nose Technology to Identify Early Lung Cancer | 2027-01-25 |
| NCT04716946Memorial Sloan Kettering Cancer CenterTreating Early-stage Non-Small Cell Lung Cancer With Durvalumab and Radiation Therapy | 2027-02 |
| NCT00579514Memorial Sloan Kettering Cancer CenterGermline Alterations of Tumor Susceptibility Genes in New York Cancer Patients | 2027-03 |
| NCT02434809Memorial Sloan Kettering Cancer CenterRespiratory Motion-Corrected Cone-Beam CT and Intratreatment Gating Based on Electromagnetic Transponders to Reduce Target Position Uncertainty in Radiation Treatment of Lung Malignancies | 2027-04 |
Add all 15 to your calendar (.ics) → With an account.
Among the 108 studies in Lung Neoplasms by Memorial Sloan Kettering Cancer Center, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The purpose of this study is to better understand communication between patients with lung cancer and their clinicians. The investigators are also interested in patient's perceptions of the quality of communication with his/her clinician and how these perceptions may impact patient outcomes. The clinician participating in this study and has given us permission to approach his/her eligible patients for study participation.
MSK thoracic clinic, pulmonary clinic
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Clinician Inclusion Criteria:
Exclusion Criteria:
Clinician Exclusion Criteria
Following informed consent, the patient will complete the patient questionnaire, either electronically, by phone, or on paper. Patients who prefer to complete the survey electronically will be emailed a link to access to a secure electronic (web-based) version of the study assessment which they will have access to from any computer. We will include an introductory email with the survey link. Will audio-record actual patient-physician clinical consultations with lung cancer patients at Memorial Sloan Kettering (MSK). Completing the survey will take about 15 minutes. Answer a few open-ended questions about the consultation with the doctor. We will audio record your answers to these questions. This will take about 15 minutes.
Behavioral: Questionnaire · Behavioral: Patient Interview · Behavioral: Audio recordings of clinical consultations
Will have 5 visits/consultations with their patients audio recorded.
Behavioral: Audio recordings of clinical consultations
Following informed consent, the patient will complete the patient questionnaire, either electronically, by phone, or on paper. Patients who prefer to complete the survey electronically will be emailed a link to access to a secure electronic (web-based) version of the study assessment which they will have access to from any computer. Completing the survey will take about 15 minutes.
Behavioral: Questionnaire
Following informed consent, clinicians will be scheduled to participate in a 2 hour training on empathic communication with lung cancer patients. Surveys will be collected from 6 patients (3 pre-training, 3 post-training). Clinicians will complete one standardized patient assessment before training (pre-SPA) and one assessment after training (post-SPA). These are 12-minute video-recorded clinic consultations with standardized patients (trained actors).
Behavioral: 2-hour empathic communication skills training · Behavioral: Standardized Patient Assessments · Behavioral: Training evaluation · Behavioral: Patient recruitment
patients will fill out a questionnaire about their perceived stigma, satisfaction with communication, and psychological distress.
Then they will participate in a brief in-person interview about their perceived stigma during the clinical consultation
Patients will fill out a questionnaire about their perceived stigma and satisfaction with their clinician's communication.
2-hour empathic communication skills training
pre-training SPA, post-training SPA
Clinicians will complete an evaluation assessing the empathic communication training module.
6 of the clinician's patients (3 pre-training, 3 post-training) will be recruited to complete brief surveys assessing clinician communication
Part 1: Systematic coding of clinical encounters and the perceived stigma within the clinical consultation
interview along with patient-reported data from the post-consultation questionnaire will be used.
Time frame: 1 year
Part 1: All variables (stigma, satisfaction with communication, psychological distress)
will be measured via post-consultation questionnaires
Time frame: 1 year
Part 2: We will pilot test the effectiveness of the empathic communication skills training module
for clinicians: physicians, nurse practitioners, physician assistants, fellows, residents, clinical nurses, and clinical nurse specialists by using the communication skills training module
Time frame: 1 year
# of patients referred to MSK's Tobacco Treatment Program (TTP)
will be determined via review of the medical record and/or Tobacco Treatment Program database
Time frame: 1 year
PDFs hosted by the registry, ClinicalTrials.gov.
Started Jan 2016 (actual). Primary completion is estimated for Jan 2027, 132 months after the start.
How these figures are worked out, and which studies are left out of them.
This study is active, not recruiting, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Memorial Sloan Kettering Cancer Center →